Text mining tool targets enterprise search
Linguamatics has launched the latest release of its natural language processing (NLP)-based text mining and analytics platform I2E 4.2 introducing integrated charting and graphing to provide visual analytics for results extracted from large volumes of unstructured data. I2E 4.2 includes new capabilities to support the integration of semantically enriched data into enterprise search engines to enhance the search experience for a wider audience.
The integrated visualisation capabilities in I2E 4.2 will allow users to gain a comprehensive view of large or complex data sets with the ability to filter down to the information of most interest, making it easier to access the most important information faster and share results throughout the organisation thus enabling more rapid decision support and increased speed to insight.
The new semantic enrichment functionality enables I2E to automatically identify and mark up concepts and relationships within data already used by enterprise search engines and link these to I2E's domain knowledge to provide improved search results.
David Milward, Linguamatics CTO, commented "We are now working to a shorter release cycle, allowing us to respond in a more agile way to customer requirements. We’re excited about the increasing demand for I2E in semantic enrichment for enterprise search platforms such as Microsoft SharePoint, and have delivered dedicated functionality to support that".
Other product enhancements include index optimisation which provides reductions in index sizes of over 70% compared to I2E 4.0, leading to savings in storage costs. This is particularly significant as customers scale up their enterprise text mining operations to deal with the challenges of big data.
Linguamatics' customers include 16 of the top 20 global pharmaceutical companies, the US Food and Drug Administration (FDA), leading US hospitals, cancer institutes and academic research centres.
Commenting on the company’s performance in 2013, John M. Brimacombe, Executive Chairman of Linguamatics, said: "Our continued growth and success comes from our ability to respond to the demanding requirements of the pharmaceutical and healthcare industries to solve their big data problems. We’re delivering an innovative and market-leading NLP platform to answer many difficult and high-value questions from genomics through to patient care. I'm excited about our future development plans and their potential impact on helping to bring drugs to market faster and improve patient outcomes.”